Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[<i>h</i>]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity.

Biomolecules·2026
Same author

Rose Bengal-Incorporated Supramolecular Gels as a Topical Platform for Localized Antimicrobial Photodynamic Therapy.

International journal of molecular sciences·2025
Same author

Design, Synthesis and Biological Evaluation of Chromeno[3,4-<i>b</i>]xanthones as Multifunctional Agents for Alzheimer's Disease.

ACS chemical neuroscience·2025
Same author

YAT2150: Overcoming limitations of traditional amyloid dyes in aggregation studies.

Bioorganic & medicinal chemistry·2025
Same author

Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencing.

Frontiers in microbiology·2025
Same author

Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties.

Pharmaceutics·2024

Related Experiment Video

Updated: Jun 28, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K

In Vivo Assays for Amyloid-Related Diseases.

Alba Espargaró1,2, Irene Álvarez-Berbel1, Maria Antònia Busquets1,2

  • 11Department of Pharmacy and Pharmaceutical Technology and Department of Physical Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain;

Annual Review of Analytical Chemistry (Palo Alto, Calif.)
|April 10, 2024
PubMed
Summary

Amyloid-related diseases like Alzheimer's and Parkinson's involve protein aggregates. This review outlines in vivo analytical methods crucial for understanding these diseases and developing new treatments in animal models.

Keywords:
amyloidamyloid-related diseasesconformational diseasesneurodegenerative diseasesprotein misfolding

More Related Videos

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-&#946; and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

26.8K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.3K

Related Experiment Videos

Last Updated: Jun 28, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-&#946; and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

26.8K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.3K

Area of Science:

  • Neuroscience and Pharmacology
  • Biochemistry and Molecular Biology

Background:

  • Amyloid-related diseases, including Alzheimer's and Parkinson's, stem from abnormal amyloid fibril accumulation.
  • Animal models are crucial for studying disease mechanisms and therapeutic development, despite ethical considerations.

Purpose of the Study:

  • To categorize and review primary analytical methods used in in vivo assays for amyloid-related diseases.
  • To emphasize the importance of these methods in advancing disease understanding and therapy development.

Main Methods:

  • Review of standardized analytical techniques applied in animal models.
  • Categorization of methods based on their application in assessing amyloid fibril formation, propagation, and drug pharmacokinetics/pharmacodynamics.

Main Results:

  • Identified a range of analytical techniques essential for in vivo studies.
  • Highlighted the standardization of methods across different animal models.

Conclusions:

  • Standardized analytical methods in animal models are vital for understanding amyloid-related diseases.
  • These methods are indispensable for the discovery and development of effective therapies for neurodegenerative disorders.